James Walter Glasheen serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, James Walter Glasheen has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2018 involved receiving (via award) 3,962 shares valued at $6.9K.
James Walter Glasheen currently holds 1,419,489 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Walter Glasheen has been a net neutral trader of RVNC stock. They have purchased $0 and sold $0 worth of shares.
James Walter Glasheen's most recent insider trade was on Feb 5, 2018, when they sold 3,962 shares at $1.73 per share.
Get notified when new Form 4 filings are submitted
| $0.52 |
| Discretionary |
| Jul 6, 2017 | SLNO | $6.8K | Award | 11,213 | $0.61 | Discretionary |
| Apr 7, 2017 | CAPN | $1.6K | Award | 2,578 | $0.63 | Discretionary |
| Feb 11, 2014 | RVNC | $0 | Exercise | 149 | $N/A | Discretionary |
| Feb 11, 2014 | RVNC | $0 | Conversion | 16,703 | $N/A | Discretionary |
| Feb 11, 2014 | RVNC | $0 | Conversion | 34,427 | $N/A | Discretionary |
| Feb 11, 2014 | RVNC | $0 | Conversion | 622,648 | $N/A | Discretionary |
| Feb 11, 2014 | RVNC | $0 | Exercise | 52,087 | $N/A | Discretionary |